JP Morgan starts CeriBell coverage with 'overweight' rating

CeriBell

05/11/2024 16:36

** Medical technology company CeriBell's  CBLL.O  shares up 2.4%
to $26.87
    ** J.P. Morgan initiates CBLL coverage with "overweight"
rating
    ** Brokerage says the company developed a portable hardware
and AI-powered software to diagnose and monitor patients with
non-convulsive seizures in the hospital setting
    ** J.P. Morgan adds CBLL operates in the highly
under-penetrated acute care seizure market worth ~$3 billion,
with room to expand into new clinical indications
    ** Brokerage sets PT at $32, a ~22% upside on stock's last
close
** Including session's moves, CBLL's stock has gained ~15.6%
since its Nasdaq debut in October 
     

(Reporting by Prakhar Srivastava in Bengaluru)
((mailto:Prakhar.srivastava2@thomsonreuters.com))